Latest News for: generic
Edit
Punjab health dept to take action against govt doctors not prescribing generic medicines
Hindustan Times 15 Feb 2026
....
Edit
GreenBanana SEO Discusses the Shift Away from Generic Keyword Pages in Google’s Latest Algorithm Update
Bennington Banner 13 Feb 2026
February 12, 2026 - PRESSADVANTAGE - ....
Edit
Securing a Healthier Future Through Generic Drugs
The Epoch Times 13 Feb 2026
Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to families ... ....
Edit
Idaho Press-Tribune
12 Feb 2026
State AG announces $17.85M in settlements for national generic drug price-fixing cases
Edit
Rutland Herald
12 Feb 2026
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))
New sublingual delivery system designed to provide more rapid relief from nausea caused by cancer medicines ....
Edit
DifGen Pharmaceuticals LLC Receives USFDA Approval for Fluorometholone Ophthalmic Suspension, 0.1% - Expanding Its Complex Generic Portfolio
PR Newswire 12 Feb 2026
12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company, today announced that it has received approval from the U.S ... This is only the second generic USFDA approval of this complex suspension product.
Edit
Attorney General Labrador Announces $17.85 Million in Settlements in Ongoing Generic Drug Price-Fixing Conspiracy Cases (State of Idaho Office of the Attorney General)
Public Technologies 12 Feb 2026
Home Newsroom Attorney General Labrador Announces $17.85 Million in Settlements in Ongoing Generic Drug Price-Fixing Conspiracy Cases ... Any Idahoan who paid for these generic drugs deserves to file a claim and get some money back.".
Edit
Dolley v. Sallie Mae Bank - Order (I) Setting Aside Entry of Default and (II) Scheduling Pretrial Conference with Related Deadlines (related document(s):14 Generic Motion filed by Defendant Sallie Mae Bank) (kef) (United States Bankruptcy Court for the District of Maine)
Public Technologies 12 Feb 2026
). UNITED STATES BANKRUPTCY COURT DISTRICT OF MAINE. In re.. Willa M. Dolley. Debtor. Willa M. Dolley. Plaintiff. v. Sallie Mae Bank. Defendant. Chapter 7. Case No. 25-10201. Adversary Proceeding No. 25-01003 ORDER (I) SETTING ASIDE ENTRY OF DEFAULT AND ... No. 5] ... No. 9].
Edit
Proposal to adopt a new Rule 5.2(j)(9) to permit the generic listing and trading of Class Exchange-Traded Fund Shares, and make certain conforming changes to the Exchange’s rules to accommodate the proposed listing of Class ETF Shares. (NYSE Group Inc)
Public Technologies 12 Feb 2026
Edit
Proposal to adopt a new Rule 5.2(j)(9) to permit the generic listing and trading of Class Exchange-Traded Fund Shares and make certain conforming changes to the Exchange’s rules to accommodate the proposed listing of Class ETF Shares. (NYSE Group Inc)
Public Technologies 12 Feb 2026
The Exchange proposes to (1) adopt a new Rule 5.2(j)(9) to permit the generic listing and trading, or trading pursuant to unlisted trading privileges, of Class ETF Shares, and (2) make certain ...
Edit
Generic East vs. Original West, by Ricardo Duchesne
The Unz Review 12 Feb 2026
While non-Western civilizations made essential, generic foundational contributions that appeared independently across early societies, ... Generic Foundational Achievements in Early Eastern Civilizations.
Edit
OneSource, Hikma get approval for generic Ozempic in Saudi Arabia
Business Line 11 Feb 2026
Semaglutide is the active ...
Edit
NCHHSTP Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (The eRulemaking Program)
Public Technologies 11 Feb 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 129430994) .
Edit
Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse
The Call 10 Feb 2026
Global Generics ... Complex Generics. Viatris continues to innovate in high-barrier-to-entry generics, such as generic Sandostatin LAR and various injectable formulations, which face less competition and offer better margins than traditional tablets.
- 1
- 2
- Next page »